Biogen Idec executives and representatives for Carl Icahn said yesterday they planned to meet and work with each other in the near future.
(Mark Lennihan/Associated Press/File 2007)
Boston Capital
Back to the drawing board
Biogen Idec executives and representatives for Carl Icahn said yesterday they planned to meet and work with each other in the near future.
(Mark Lennihan/Associated Press/File 2007)
It was over before it began. After months of campaigning and badgering, billionaire investor Carl Icahn's slate of three directors challenging company nominees at Biogen Idec Inc. came up on the short end of a shareholder vote yesterday, and it didn't appear to be a close contest. (Full article: 923 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
